Novel PD-1 inhibitor and application thereof

Abstract

The invention relates to a steroidal derivative as a PD-1 blocker and application thereof, in particular to a compound shown as a formula I below, a medicinal composition containing the compound shownas the formula I below, and application of the compound to treatment of PD-1 mediated related diseases and preparation of medicines for treating the PD-1 mediated related diseases.

Description

technical field

[0001] The invention relates to the field of medicinal chemistry; specifically, the invention relates to steroid derivatives targeting hPD-1 protein and applications thereof. Background technique

[0002] As we all know, the human body has a powerful and complex immune system, which can resist invading bacteria and viruses externally, remove damaged and aging cells internally, and even monitor mutated cells. The immune system is mainly divided into antigen presenting cells (APC) and T cells. APCs can process and present antigens, T cells receive the specific antigen signal presented by APCs, and then continue to proliferate and activate under the action of co-stimulatory molecules on the surface of APCs. The activation of T cells requires not only the stimulation of the first signal provided by APC, but also the stimulation of the second signal provided by co-stimulatory molecules. These co-stimulatory molecules not only provide co-stimulatory signals to en...

Examples

Embodiment 1

[0163] Example 1. Human PD-1 expression vector construction

[0164] According to relevant literature, the target gene was selected as the 34-150 amino acids of human PD-1. The target gene was cloned into the pET-28a vector using NCoI and NdeI restriction sites. Firstly, specific primers were designed according to the two restriction sites of NCoI and NdeI to amplify the human PD-1 gene by PCR. Then use the traditional cloning method to double digest the carrier plasmid and PCR product with two restriction enzymes NCoI and NdeI respectively, then connect them under the action of T4 ligase to form a recombinant plasmid, and finally transform the recombinant plasmid into the large intestine Bacillus DH5α competent cells. Single clones were picked for identification after overnight culture.

Embodiment 2

[0165] Example 2. Expression and purification of human PD-1 protein

[0166] Select the bacterial liquid with a completely matching sequence after the company's sequencing and culture it overnight, extract the plasmid, and then transform the plasmid into the expression host E.coli BL21(DE3) for expression. A single clone transformed into E.coli BL21(DE3) was picked, placed in 20 mL of 2×YT medium containing kanamycin, and cultured in a shaker at 37° C. overnight. The next day, the small culture products were transferred to TB medium containing kanamycin, cultured at 37°C until the OD600 was 0.6-0.8, and induced by adding 0.5mM IPTG at 37°C for 5-7h. Collect bacteria by centrifugation at 4000rpm, lyse Escherichia coli with lysis buffer (50mM Tris-HCl, pH 8.0, 50mM NaCl, 1mM DTT, 0.5mMEDTA, 5% glycerol), then high-pressure crush, centrifuge at 12000rpm for 60min, take precipitation. Wash with washing buffer (20 mM Tris-HCl, pH 8.0, 2M urea, 2.5% Triton X-100) three times, and ...

Embodiment 3

[0167] Example 3. Identification of human PD-1 protein

[0168] The purified human PD-1 protein was subjected to 14% SDS-PAGE gel electrophoresis, and then transferred to a membrane. The transfer current was set to 300mA, and the transfer time was 45min. The membrane was then blocked with 5% skim milk powder for 2 h at room temperature. After removal, incubate overnight at 4°C with mouse anti-human PD-1 monoclonal antibody, rinse three times in 1×TBST solution, incubate with goat anti-mouse monoclonal antibody at room temperature for 2 hours, and rinse three times in 1×TBST solution. After adding the developing solution, develop under the automatic chemiluminescence image analysis system. The results are shown in 2, there is a protein band between 10-15kDa, and it can be visualized under the PD-1 antibody, thus indicating that the purified protein is indeed human PD-1 protein.

technical field

[0001] The invention relates to the field of medicinal chemistry; specifically, the invention relates to steroid derivatives targeting hPD-1 protein and applications thereof. Background technique

[0002] As we all know, the human body has a powerful and complex immune system, which can resist invading bacteria and viruses externally, remove damaged and aging cells internally, and even monitor mutated cells. The immune system is mainly divided into antigen presenting cells (APC) and T cells. APCs can process and present antigens, T cells receive the specific antigen signal presented by APCs, and then continue to proliferate and activate under the action of co-stimulatory molecules on the surface of APCs. The activation of T cells requires not only the stimulation of the first signal provided by APC, but also the stimulation of the second signal provided by co-stimulatory molecules. These co-stimulatory molecules not only provide co-stimulatory signals to en...

Examples

Embodiment 1

[0163] Example 1. Human PD-1 expression vector construction

[0164] According to relevant literature, the target gene was selected as the 34-150 amino acids of human PD-1. The target gene was cloned into the pET-28a vector using NCoI and NdeI restriction sites. Firstly, specific primers were designed according to the two restriction sites of NCoI and NdeI to amplify the human PD-1 gene by PCR. Then use the traditional cloning method to double digest the carrier plasmid and PCR product with two restriction enzymes NCoI and NdeI respectively, then connect them under the action of T4 ligase to form a recombinant plasmid, and finally transform the recombinant plasmid into the large intestine Bacillus DH5α competent cells. Single clones were picked for identification after overnight culture.

Embodiment 2

[0165] Example 2. Expression and purification of human PD-1 protein

[0166] Select the bacterial liquid with a completely matching sequence after the company's sequencing and culture it overnight, extract the plasmid, and then transform the plasmid into the expression host E.coli BL21(DE3) for expression. A single clone transformed into E.coli BL21(DE3) was picked, placed in 20 mL of 2×YT medium containing kanamycin, and cultured in a shaker at 37° C. overnight. The next day, the small culture products were transferred to TB medium containing kanamycin, cultured at 37°C until the OD600 was 0.6-0.8, and induced by adding 0.5mM IPTG at 37°C for 5-7h. Collect bacteria by centrifugation at 4000rpm, lyse Escherichia coli with lysis buffer (50mM Tris-HCl, pH 8.0, 50mM NaCl, 1mM DTT, 0.5mMEDTA, 5% glycerol), then high-pressure crush, centrifuge at 12000rpm for 60min, take precipitation. Wash with washing buffer (20 mM Tris-HCl, pH 8.0, 2M urea, 2.5% Triton X-100) three times, and ...

Embodiment 3

[0167] Example 3. Identification of human PD-1 protein

[0168] The purified human PD-1 protein was subjected to 14% SDS-PAGE gel electrophoresis, and then transferred to a membrane. The transfer current was set to 300mA, and the transfer time was 45min. The membrane was then blocked with 5% skim milk powder for 2 h at room temperature. After removal, incubate overnight at 4°C with mouse anti-human PD-1 monoclonal antibody, rinse three times in 1×TBST solution, incubate with goat anti-mouse monoclonal antibody at room temperature for 2 hours, and rinse three times in 1×TBST solution. After adding the developing solution, develop under the automatic chemiluminescence image analysis system. The results are shown in 2, there is a protein band between 10-15kDa, and it can be visualized under the PD-1 antibody, thus indicating that the purified protein is indeed human PD-1 protein.

Images